Derya Tilki

72PUBLICATIONS
151CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Veterinary diagnosis and diagnosticsMedical infection agents (incl. prions)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Jun 16, 2026
Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy.

|Dec 01, 2025
Optimizing prostate biopsy: the role of targeted, regional, and systematic approaches.

Kayhan Tarim, Hasim Bakbak, Ahmet Furkan Sarikaya

|Sep 02, 2025
Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model.

Carolin Siech, Helge von Kriegstein, Mike Wenzel

|Apr 29, 2025
6-[(1,4-Naphthoquinone-2-yl)methyl]thio-Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer.

Tobias Busenbender, Dmitry N Pelageev, Jessica Hauschild

|Feb 27, 2025
Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate-Risk Prostate Cancer Patients With Node-Negative PSMA PET.

Baris Esen, Hulya Seymen, Ayşe Armutlu

|Feb 13, 2025
Patient-Reported Outcome Measures and Decision Regret After Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following Radiotherapy or Focal Therapy.

Fabian Falkenbach, Johanna Hagemann, Francesca Ambrosini

Pageof 12

Frequent Collaborators

18 joint publications

Mike Wenzel

15 joint publications

Christoph Würnschimmel

10 joint publications

Felix Preisser

10 joint publications

Fred Saad